• Every dose printed on the panel
  • Prices shown per serving
  • Cautions printed on the page
  • 30-day money-back guarantee
Which routine is right for you?See your routine

Research review

Does L-carnitine help with obesity? What the research does and doesn't show

The evidence doesn't support L-carnitine as a meaningful way to treat obesity. The largest pooled trials, run mostly in adults with overweight or obesity, found only a small average difference in body weight, no consistent effect on waist circumference or body-fat percentage in the highest-quality trials, and a separate network analysis found carnitine ranked among options for an obesity-related marker in women with PCOS specifically — evidence too thin to call it an obesity treatment.

By Electric Tiger Editorial

The evidence doesn't support L-carnitine as a meaningful way to address obesity. The largest pooled trials, run mostly in adults with overweight or obesity, found only a small average difference in body weight against control groups, and that difference didn't hold up for waist circumference or body-fat percentage once only the highest-quality trials were counted.

What the evidence doesn't support

It doesn't support L-carnitine as something that changes obesity-related outcomes meaningfully on its own, independent of diet and exercise. It doesn't support a benefit on waist circumference or body-fat percentage — no trial found one that held up under rigorous-trial-only analysis. And it doesn't support treating L-carnitine as interchangeable with medical or lifestyle approaches to obesity; nothing in the research below was designed or powered as an obesity treatment trial in the way a drug trial would be.

What the trials found

Two meta-analyses have pooled the randomized trials testing L-carnitine's effect on body weight, largely in adults with overweight or obesity. A 2016 meta-analysis in Obesity Reviews combined 9 trials (911 adults) and found a 1.33 kg average body-weight difference versus control groups, with the size of that difference shrinking significantly the longer a trial ran. A larger 2020 meta-analysis in Clinical Nutrition ESPEN, combining 37 trials (2,292 adults, mostly with overweight or obesity), found a smaller but still statistically significant 1.21 kg difference in body weight, 0.24 kg/m² in BMI, and 2.08 kg in fat mass — but no significant difference in waist circumference or body-fat percentage. Critically, when the authors of that 2020 analysis restricted their pooled results to only the highest-quality trials, just the body-weight finding held up; the BMI and fat-mass differences did not. A dose-response analysis in the same paper found no added body-weight benefit above roughly 2,000 mg a day.

A separate line of evidence comes from a 2025 network meta-analysis in Reproductive Biology and Endocrinology, pooling 79 trials (5,501 women) testing nutritional supplements in polycystic ovary syndrome (PCOS) — a condition often associated with obesity. That analysis ranked carnitine among the more effective options for an obesity-related measure in that specific population. The retrievable abstract doesn't report the dose used, the size of the effect, or which specific measure (weight, BMI or waist circumference) improved, and the population is women diagnosed with PCOS, not a general audience trying to manage weight — a meaningfully different, more clinically supervised context than an over-the-counter supplement decision.

Study Population Trials (n) Finding Certainty
Pooyandjoo 2016 Adults, mostly overweight/obese 9 RCTs (n=911) -1.33 kg body weight vs. control; effect shrank in longer trials Moderate — pooled RCTs, effect not stable over time
Talenezhad 2020 Adults, mostly overweight/obese 37 RCTs (n=2,292) -1.21 kg body weight; BMI and fat-mass effects didn't hold in high-quality-only analysis Low for BMI/fat mass; higher for body weight alone
Zhao 2025 (network meta-analysis) Women with PCOS 79 RCTs (n=5,501), multi-supplement Carnitine ranked effective for an obesity-related measure in PCOS; dose/effect size not given in abstract Low — network meta-analysis, specific effect not quantified

Questions people ask

Does L-carnitine burn fat or cause fat loss?

The two general-population meta-analyses found a small average difference in body weight and, in the larger analysis, fat mass — but the fat-mass finding didn't hold up when only the highest-quality trials were counted, and neither trial isolated fat loss as distinct from overall body-weight change.

Is L-carnitine good for fat loss at a specific dose, like 3,000 mg?

The dose-response modeling in the 2020 meta-analysis found no additional body-weight benefit above roughly 2,000 mg a day — a higher labeled dose (3,000 mg or more) isn't associated with a bigger effect in that data.

Does L-carnitine work for weight loss without exercise?

The pooled trials didn't consistently isolate exercise from no-exercise conditions, so there's no trial-based answer to whether it works on its own without any change in diet or activity.

Is L-carnitine different for people who are already obese versus people with a healthy weight?

Most of the general-population trials enrolled adults with overweight or obesity specifically, so the modest effects reported above already reflect that population — they weren't measured in people at a healthy weight to begin with.

When to talk to a doctor

L-carnitine is not a treatment for obesity, and nothing in the research above supports using it as a substitute for medical evaluation, a structured eating plan, or a doctor-guided weight-management program. If obesity is a health concern for you, that's a conversation for a doctor, who can evaluate options with a stronger evidence base than an over-the-counter supplement. If you're pregnant, nursing, take prescription medication, or have an existing health condition, talk to a doctor before adding any supplement.

Related reading: what is L-carnitine?, L-carnitine dosage, and what does L-carnitine do for women?.

Sources

  1. The effect of (L-)carnitine on weight loss in adults: a systematic review and meta-analysis of randomized controlled trials Obesity reviews : an official journal of the International Association for the Study of Obesity · 2016 · PMID 27335245A meta-analysis of 9 trials found a small average body-weight difference with carnitine versus control, and the effect shrank the longer the trial lasted.
  2. Effects of l-carnitine supplementation on weight loss and body composition: A systematic review and meta-analysis of 37 randomized controlled clinical trials with dose-response analysis Clinical nutrition ESPEN · 2020 · PMID 32359762The largest meta-analysis found a small average reduction in body weight, BMI and fat mass, but no effect on waist circumference or body-fat percentage, and only the body-weight finding held up in the highest-quality trials.
  3. The effectiveness of nutritional supplements in improving polycystic ovary syndrome in women: a systematic review and network meta-analysis Reproductive biology and endocrinology : RB&E · 2025 · PMID 40611279A network meta-analysis of 79 trials found chromium, inositol and omega-3 beneficial for lipid markers and insulin resistance respectively, but no supplement outperformed placebo for testosterone, SHBG, DHEA or inflammation markers.

*These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.